Development of a deep neural network model based on high throughput screening data for predicting synergistic estrogenic activity of binary mixtures for consumer products.

Journal: Journal of hazardous materials
PMID:

Abstract

A paradigm of chemical risk assessment is continuously extending from focusing on 'single substances' to more comprehensive approaches that examines the combined toxicity among different components in 'mixtures.' This change aims to account for the cocktail effect arising from the toxicological interactions in mixtures, which can lead to increased risks. More than 1000 potential endocrine-disrupting chemicals (EDCs) have been reported, and they can be included in different industrial and consumer chemical products and released to the environment as pollutants of emerging environmental concern. Although extensive studies involving both experiments and predictions have investigated individual EDCs, predictions of their synergistic effects are still relatively lacking, an area that requires further investigation. In this study, we extensively investigated substances in consumer products, mainly marketed in South Korea, that might exhibit estrogenic activity or reproductive toxicity. A high throughput screening (HTS) assay based on OECD Test Guideline 455 for hERαHeLa-9903 cells was constructed, and 435 substances were screened using the HTS. Thirty-five (potential) estrogenic agonists were selected, and their 1412 binary mixtures that could be prepared in four different ratios were systematically tested, considering the available effective concentrations of substances and the solubility of their resulting mixtures. The best empirical dose-response curves of 35 substances and 917 mixtures were derived in this study. Based on the HTS data, a deep neural network model was developed (area under the curve (AUC): 0.837-0.881) and compared with a random forest model (AUC: 0.656-0.829) to screen for the synergistic estrogenic activity of binary mixtures.

Authors

  • Jongwoon Kim
    Bradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, 24061, USA.
  • Seung-Jin Lee
    College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, South Korea.
  • Daeyoung Jung
    Center for Rare Disease Therapeutic Technology, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
  • Hyun Young Kim
    Center for Rare Disease Therapeutic Technology, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
  • Jung-In Lee
    Center for Rare Disease Therapeutic Technology, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
  • Myungwon Seo
    Chemical Analysis Center, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
  • Sunmi Kim
    Department of Biomedical Engineering and Research Institute of Biomedical Engineering, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
  • Jiwon Choi
    Bioinformatics & Molecular Design Research Center, Yonsei University, Seoul 03722, South Korea.
  • Wook-Joon Yu
    Developmental and Reproductive Toxicology Research Group, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea. yuwj@kitox.re.kr.
  • Heeyeong Cho
    Center for Rare Disease Therapeutic Technology, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea; Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea. Electronic address: hycho@krict.re.kr.